Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Head & Neck 2Genitourinary 2Gastrointestinal 2

Conditions

Carcinoma, Renal Cell 52Kidney Neoplasms 43Melanoma 23Neoplasm Metastasis 14Uterine Cervical Neoplasms 8Breast Neoplasms 5Vaginal Neoplasms 4Penile Neoplasms 4Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Anus Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Merkel Cell 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Carcinoma, Hepatocellular 2Wilms Tumor 1

Interventions

fludarabine 3Radiotherapy 3Cyclophosphamide 3entinostat 2aldesleukin 2aflibercept 2Trastuzumab 2Nivolumab 2Adoptive Transfer 2trastuzumab deruxtecan 1tivozanib 1tipifarnib 1rocakinogene sifuplasmid 1pembrolizumab 1oncogene protein E7, Human papillomavirus type 16 1durvalumab 1bintrafusp alfa protein, human 1atezolizumab 1Vorinostat 1VGX-3100 1Specimen Handling 1Ritonavir 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1MEDI0457 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vulvar Neoplasms × aldesleukin × Genitourinary × Clear all
NCT05639972 2026-02-27

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Rutgers, The State University of New Jersey

Phase 1/2 Recruiting
15 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05686226 2026-02-27

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Rutgers, The State University of New Jersey

Phase 2 Recruiting
20 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Neoplasm Metastasis, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡